| Mark Awadalla |
Mark Awadalla is currently the Vice President-Clinical Operations at Capricor Therapeutics, Inc. He previously worked as the Executive Director-Clinical Operations at Mustang Bio, Inc. from 2018 to 2020 and as the Vice President-Clinical Research & Development at Celularity, Inc. from 2020 to 2023. Mr. Awadalla completed his undergraduate degree at Stockton University. |
| Anthony J. Bergmann |
Anthony J. Bergmann has held the following positions in his career: Treasurer & Finance Director at Capricor, Inc. starting in 2013, and Chief Financial Officer at Capricor Therapeutics, Inc. starting in 2018. He completed his undergraduate degree at Providence College in 2008 and obtained an MBA from USC Marshall School of Business in 2013. |
| Kristi A. H. Elliott |
Kristi A. H. Elliott is currently the Chief Scientific Officer at Capricor Therapeutics, Inc. She previously worked as the Senior Director of Stem Cell & Exosome Development at Precigen, Inc. She completed her undergraduate and graduate degrees at Rutgers State University of New Jersey and obtained her doctorate degree from The Johns Hopkins University School of Medicine. |
| Ming Hao Sun |
Ming Hao Sun is currently the Vice President-Research & Product Development at Capricor Therapeutics, Inc. Prior to this, he was the Director-Stem Cell Research at Trans Ova Genetics LC from 2019 to 2020. From 2012 to 2019, he served as the General Manager-San Diego Site at Precigen, Inc. Dr. Sun holds a doctorate degree from The Pennsylvania State University and has completed his undergraduate and graduate studies at Wuhan University. |
| Frank Litvack |
Frank Litvack is the founder of iTherX Pharmaceuticals, Inc. (founded in 1992), Progressive Angioplasty Systems, Inc. (founded in 1989), Savacor, Inc. (founded in 2000), Conor Medsystems LLC (founded in 2002), Fasturn, Inc. (founded in 1999), TrialTech Medical, Inc. (founded in 2018), and VIDA FLaSH Acquisitions (founded in 2021). He held various titles at these companies, including Director, Chairman & Chief Executive Officer, and Chief Executive Officer & Director. Dr. Litvack was also the founder of Advanced Interventional Systems, Inc., Pura Vida Investments LLC, and Levation Pharma Ltd. His current job(s). included Executive Chairman at Capricor, Inc. (since 2012), Chairman at Credence MedSystems, Inc., Chairman at V-Wave Ltd., Executive Chairman at Capricor Therapeutics, Inc. (since 2012), Director at Cardiovascular Research Foundation, Director at Tanenbaum Open Science Institute, Professor at the University of California, Los Angeles, Member at the University of California, Davis, Member at Calmedica LLC (since 1985), Member at. Pura Vida Investments LLC (Private Equity), and Member at Wilhareka Partners LLC (since 2020). His former job(s) include Director at One Lambda, Inc., Director at ReCor Medical, Inc., Director at CathWorks Ltd., Co-Director at Cardiovascular Intervention Center, Director at MedAvail, Inc., Director at MedAvail Holdings, Inc., and Principal at Cedars-Sinai Medical Center (from 1989 to 1997). Dr. Litvack's education includes undergraduate and doctorate degrees from McGill University. |
| Linda Marbán |
Linda Marbán is the founder and the Chief Executive Officer of Capricor, Inc., which was founded in 2005. She is currently the President, Chief Executive Officer, and Director of Capricor Therapeutics, Inc., starting in 2013. Dr. Marbán previously worked as an Assistant Professor at The Johns Hopkins University from 2000 to 2003. She holds a doctorate degree from Case Western Reserve University, conferred in 2001, and an undergraduate degree from the University of Maryland. |
| Philip J. Gotwals |
Philip J. Gotwals is currently an Independent Director at Capricor Therapeutics, Inc. He previously held positions as a Senior Director-Early Development at Biogen, Inc. from 2004 to 2006, Vice President-Business Development & Licensing at Novartis Institutes for Biomedical Research, Inc. from 2009 to 2023, and Vice President-Program Management at Altus Pharmaceuticals, Inc. from 2006 to 2009. He was also a Partner at Redsky Partners LLC until 2005. Dr. Gotwals obtained his undergraduate degree from Amherst College and his doctorate from the University of California, Berkeley. |
| Michael Kelliher |
Michael Kelliher is currently an Independent Director at Capricor Therapeutics, Inc. since 2023 and an Executive VP-Corporate Development & Strategy at Ardelyx, Inc. since 2024. Previously, he worked as a Group Vice President-Merger & Acquisition at Horizon Therapeutics Plc. He completed his undergraduate degree at University College Cork. |
| Paul G. Auwaerter |
Paul G. Auwaerter is currently the Chairman at the Infectious Diseases Society of America. He is also an Independent Director at Capricor Therapeutics, Inc., a Director at the American Lyme Disease Foundation, Inc., and a Director at the Baltimore Area Council Boy Scouts of America, Inc. Additionally, he has been a Professor at The Johns Hopkins University School of Medicine since 1996. In terms of education, Dr. Auwaerter has an undergraduate and doctorate degree from The Trustees of Columbia University in The City of New York. He also holds an MBA from The Johns Hopkins University. |
| Earl M. Collier |
Earl M. Collier is currently the Chairman at Newton-Wellesley Hospital Corp. He is also an Independent Director at Capricor Therapeutics, Inc., a Director at Codex Foundation, a Trustee at Boston Athenæum, an Advisor at InCube Venture Partners LLC, a Member at The Grolier Club of New York, and a Member at Book Club of California. Previously, Mr. Collier held several positions including Chief Executive Officer & Director at deCODE genetics, Inc., Executive Chairman & Chief Executive Officer at Arsenal Medical, Inc., Chief Executive Officer & Director at Lyra Therapeutics, Inc., and Director at Capricor, Inc., Tesaro, Inc., TransMedics, Inc., Mass General Brigham, Inc., Encorium Group, Inc., and Gensight Biologics SA. He was also the President at VITAS Healthcare Corp. and Partner at Hogan & Hartson LLP. Additionally, he served as President at Genzyme Biosurgery Corp., Deputy Administrator at Centers for Medicare & Medicaid Services (US), and Deputy Administrator at US Department of Health & Human Services (DC). Mr. Collier was also the Executive VP-Cardiovascular, Oncology & Genetics at Genzyme Corp.Mr. Collier completed his undergraduate studies at Yale University and obtained a graduate degree from the University of Virginia School of Law. |
| George W. Dunbar |
George W. Dunbar's current job(s) include serving as the Executive Chairman at Akadeum Life Sciences, Inc., Director at Capricor, Inc., Director at Progenitor Life Sciences LLC, Independent Director at Capricor Therapeutics, Inc., and Managing Partner at Dunbar Group LLC. Formerly, Mr. Dunbar held positions such as Chief Executive Officer at StemCells, Inc., Chief Executive Officer at Metra Biosystems, Inc., Chief Executive Officer at Quantum Dot Corp., Chief Executive Officer & Director at Biologics, Inc., Chief Executive Officer at Epic Therapeutics, Inc., Chief Executive Officer at CytoTherapuetics, Inc., Chief Executive Officer at MedInnova Partners, Inc., President & Chief Executive Officer at ISTO Technologies, Inc., Chief Executive Officer & Director at Specialty Pharma, Inc., Chief Executive Officer at Targesome, Inc., Chief Executive Officer & Director at Cell Therapy Ltd., Chief Executive Officer & Director at Diagnostics Direct, Inc., Chief Executive Officer at Isto Biologics (Massachusetts), Executive Chairman at Avery Therapeutics, Inc., Director at Calmare Therapeutics, Inc., Director at Sonus Pharmaceuticals, Inc., Director at Accuri Cytometers, Inc., Director at KFx Medical LLC, Director at Essen Instruments, Inc., Director at Lucina Health, Inc., Director at Life Magnetics, Inc., President, Chief Executive & Financial Officer at Vericel Corp., Principal at GE Healthcare Ltd. (United Kingdom), Principal at Ares-Serono Group, and Partner at Arboretum Ventures LLC. Mr. Dunbar obtained his undergraduate degree and MBA from Auburn University. |
| David Brian Musket |
David Brian Musket is the founder of Musket Research Associates, Inc. which was founded in 1991. He held the titles of President, Secretary, Treasurer & Director from 1991 to 2016. Currently, he holds the position of Director at Capricor, Inc. since 2012, Managing Director at Promed Partners LP, and Independent Director at Capricor Therapeutics, Inc. since 2013. In the past, he held the position of Director at Matritech, Inc. in 2007, Director at Conor Medsystems LLC from 1999 to 2007, and Director at TherOx, Inc., MZT Holdings, Inc. He was also the President of ProMed Management, Inc. from 2012 to 2013. Mr. Musket completed his undergraduate degree from Boston College. |
| Karimah Es Sabar |
Karimah Es Sabar is currently the Chief Executive Officer & General Partner at Quark Venture, Inc. She is also serving as the Chairman-Health Biosciences Economic Strategy at the Government of Canada. Additionally, she holds the position of Independent Director at Capricor Therapeutics, Inc., Director at The Vancouver Prostate Centre, Director at V-Wave Ltd., Director at Phemi Systems Corp., Director at PC-TRiADD, Director at Cognetivity Neurosciences Ltd., Director at ARTMS, Inc., Director at Canary Medical, Inc., and Global Head-Marketing & Business Development at Pasteur Mérieux Connaught. Her former positions include President & Chief Executive Officer at The Centre for Drug Research & Development, Director at Knowledge First Financial, Inc., and President at LifeSciences British Columbia. Ms. Es Sabar completed her undergraduate studies at the University of Salford and the Institute of Psychiatry, Psychology & Neuroscience. |
